+Susen Rogen

Tuesday, 25 June 2013

Chinese Orthopedic Biomaterials Market:Life Sciences Market Research Reports

Life Sciences Market Research Reports
Chinese Orthopedic Biomaterials Market
Jun 24th 2013, 00:00

The Chinese orthopedic biomaterials market is expected to approach $522.3 million by 2019. The bone graft substitute segment is expected to constitute the majority of the Chinese orthopedic biomaterials market. The Chinese orthopedic biomaterials market comprises bone graft substitutes which is segmented into allografts, demineralized bone matrices (DBM) and synthetics, and hyaluronic acid (HA) viscosupplementation. The market has seen increased interest in domestic competitors and some domestic competitors are in the process of clinical trials for synthetic, DBM, and bone morphogenetic protein (BMP) products. Further growth in the overall market will be fuelled by the Chinese government improving healthcare coverage …

Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103721.

Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/chinese-orthopedic-biomaterials-market-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment